Sales for this month
May 2026Fiscal year ending March 2027The company discloses key figures related to its pet insurance business and its synergy-generating businesses aimed at realizing a “preventive insurance company.”
Generally scheduled for disclosure from the middle of each month onward. Disclosures for June, September, December and March will be made on the same day as the announcement of the quarterly financial results for each quarter.
Month April / Net Premiums Written 5,134, Month May / Net Premiums Written 5,424, Month June / Net Premiums Written 5,220, Month July / Net Premiums Written 5,175, Month August / Net Premiums Written 5,332, Month September / Net Premiums Written 5,387, Month October / Net Premiums Written 5,415, Month November / Net Premiums Written 5,280, Month December / Net Premiums Written 5,376, Month January / Net Premiums Written 5,529, Month February / Net Premiums Written 5,307, Month March / Net Premiums Written 5,518
Scope of aggregation: The group
| Item | Details |
|---|---|
| Month Covered | May 2026 |
| Fiscal Year Covered | Fiscal year ending March 2027 |
| Scope of aggregation | The group |
| Net sales for the month | ¥5,730 million |
| Year-on-year change in monthly net sales | 105.6 |
| Year-on-year change by category | Name Net Premiums Written / Year on year 105.6, Name Number of in-force policies / Year on year 107.4, Name Average renewal rate / Year on year 100, Name Doubutsu Kenkatsu program (gut flora testing) applications / Year on year 97.7, Name Patents held / Year on year 127.3, Name JARVIS Tokyo sales / Year on year Not disclosed |
| Sales by category | Net Premiums Written ¥5,730 million, Number of in-force policies 1,405,440 Engagements, Average renewal rate 88.2 %, Doubutsu Kenkatsu program (gut flora testing) applications 22,563 Engagements, Patents held 28 Engagements, JARVIS Tokyo sales ¥60,449 thousand |
| Key KPIs | Indicator name Number of in-force policies / Value 1,405,440 Engagements / Year on year 107.4 Engagements, Indicator name Average renewal rate / Value 88.2 % / Year on year 100 %, Indicator name Doubutsu Kenkatsu program (gut flora testing) applications / Value 22,563 Engagements / Year on year 97.7 Engagements, Indicator name Patents held / Value 28 Engagements / Year on year 127.3 Engagements, Indicator name JARVIS Tokyo sales / Value ¥60,449 thousand / Year on year Not disclosed |
| Monthly Commentary | The company discloses key figures related to its pet insurance business and its synergy-generating businesses aimed at realizing a “preventive insurance company.” |
| Monthly trend for the same period last year | Month April / Net Premiums Written 5,134, Month May / Net Premiums Written 5,424, Month June / Net Premiums Written 5,220, Month July / Net Premiums Written 5,175, Month August / Net Premiums Written 5,332, Month September / Net Premiums Written 5,387, Month October / Net Premiums Written 5,415, Month November / Net Premiums Written 5,280, Month December / Net Premiums Written 5,376, Month January / Net Premiums Written 5,529, Month February / Net Premiums Written 5,307, Month March / Net Premiums Written 5,518 |
| Next Scheduled Disclosure | Generally scheduled for disclosure from the middle of each month onward. Disclosures for June, September, December and March will be made on the same day as the announcement of the quarterly financial results for each quarter. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company has not provided details on the reasons for the individual increases and decreases. It explained that JARVIS Tokyo is an advanced veterinary medical facility that opened in October 2025, and that monthly sales have been disclosed since April 2026.